Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome-Reference-Cited by-同舟云学术

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome

Published:2022-06-01 Issue:6 Volume:79 Page:554
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Knupp Kelly G.¹,Scheffer Ingrid E.²,Ceulemans Berten³,Sullivan Joseph E.⁴,Nickels Katherine C.⁵,Lagae Lieven⁶⁷,Guerrini Renzo⁸⁹,Zuberi Sameer M.¹⁰,Nabbout Rima¹¹,Riney Kate¹²¹³,Shore Svetlana¹⁴¹⁵,Agarwal Anupam¹⁴,Lock Michael¹⁴¹⁶,Farfel Gail M.¹⁴,Galer Bradley S.¹⁴,Gammaitoni Arnold R.¹⁴,Davis Ronald¹⁷,Gil-Nagel Antonio¹⁸

Affiliation:

1. Department of Neurology, Children’s Hospital Colorado, Aurora

2. Austin Hospital and Royal Children’s Hospital, University of Melbourne, Melbourne, Victoria, Australia

3. Department of Paediatric Neurology, Antwerp University Hospital, Antwerp, Belgium

4. Weill Institute for Neurosciences, Benioff Children’s Hospital, University of California San Francisco, San Francisco

5. Department of Neurology, Mayo Clinic, Rochester, Minnesota

6. Steering Committee, European Reference Network EpiCARE, Lyon, France

7. Department of Paediatric Neurology, KU Leuven, Leuven, Belgium

8. Pediatric Neurology and Neurogenetics Unit, Anna Meyer Children’s Hospital, University of Florence, Florence, Italy

9. Neurobiologia e Neurogenetica dei Disturbi del Neurosviluppo, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Fondazione Stella Maris, Pisa, Italy

10. Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, United Kingdom

11. Department of Pediatric Neurology, Reference Centre for Rare Epilepsies, Necker-Enfants Malades Hospital, Imagine Institute, University Paris Descartes, Paris, France

12. Neuroscience Unit, Queensland Children’s Hospital, South Brisbane, Queensland, Australia

13. School of Clinical Medicine, University of Queensland, St Lucia, Queensland, Australia

14. Zogenix Inc, Emeryville, California

15. Now with Neurocrine Biosciences, San Diego, California

16. Now with Zogenix Inc, Haiku, Hawaii

17. Neurology and Epilepsy Research Center, Orlando, Florida

18. Department of Neurology, Epilepsy Program, Hospital Ruber Internacional, Madrid, Spain

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2791918/jamaneurology_knupp_2022_oi_220015_1653667079.68349.pdf

Reference34 articles.

1. Expert opinion on the management of Lennox-Gastaut syndrome: treatment algorithms and practical considerations.;Cross;Front Neurol,2017

2. Childhood epileptic encephalopathy with diffuse slow spike-waves (otherwise known as “petit mal variant”) or Lennox syndrome.;Gastraut;Epilepsia,1966

3. Lennox-Gastaut syndrome: a consensus approach on diagnosis, assessment, management, and trial methodology.;Arzimanoglou;Lancet Neurol,2009

4. Relationship of Lennox-Gastaut syndrome with perinatal event: a cross-sectional study.;Kumar;J Pediatr Neurosci,2015

5. Challenges in identifying Lennox-Gastaut syndrome in adults: a case series illustrating its changing nature.;Piña-Garza;Epilepsy Behav Case Rep,2016

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fenfluramine;Neurologie pro praxi;2024-09-10

2. Developmental and epileptic encephalopathies;Nature Reviews Disease Primers;2024-09-05

3. Anti-seizure Medications: Challenges and Opportunities;CNS & Neurological Disorders - Drug Targets;2024-09

4. First epileptic seizure and epilepsies in adulthood;Clinical Epileptology;2024-08-14

5. Direct serotonin release in humans shapes aversive learning and inhibition;Nature Communications;2024-08-09